Mylonza 300/300/400


Film-coated tablets
scheduling status
S4
registration number
54/20.2.8/0052.051
What Mylonza 300/300/400 contains
Tenofovir disoproxil fumarate 300 mg Lamivudine 300 mg Efavirenz 400 mg.
other ingredients
Microcrystalline cellulose, croscarmellose sodium, ferric oxide, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, sodium lauryl sulfate. Film coat: Opadry II White (macrogol, polyvinyl alcohol, talc, titanium dioxide).
Therapeutic classification
J05AR11.
© 2026 SAHPRA. ALL RIGHTS RESERVED